Hypoxia is a major regulatory factor for EPO synthesis. However, several chemically diverse antioxidants also can affect HIF-1 activity and EPO expression [11, 15, 18, 27, 31, 37, 38] . α-Lipoic acid is a very interesting antioxidant because of its anti-and prooxidative activity. It reduces superoxide and hydroxyl radicals but it can generate H 2 O 2 via auto-oxidation depending on the time and dose of its administration [26] . In animal studies, it has been shown that α-lipoic acid at doses from 12.5 mg · kg -1 to 100 mg · kg -1 body weight improved the anti-oxidative response while doses over 100 g · kg -1 induced pro-oxidative processes [7, 14] . In human studies, α-lipoic acid is used as a dietary supplement at doses from 100
to 1200 mg daily but as a medication it is recommended at high doses (up to 1800 mg · d -1 ) for a long period (up to 6 months) in diabetic neuropathy and other diseases [2, 26] . The time and dose of α-lipoic acid supplementation seems to be important for α-lipoic acid activity. In our previous study, 600 mg of α-lipoic acid revealed an antioxidant action but did not improve the haematological re-sponse [36] . Freudenthaler et al. [11] used very short-term α-lipoic acid treatment (1200 mg) with an infusion pump (20 mg · min -1 ) during 6 h hypoxia. They did not observe any changes in markers of RN/OS activity or EPO level. Nonetheless, a recent study provided evidence for the use of α-lipoic acid as an EPO adjuvant, reducing the requirement for EPO in patients undergoing haemodialysis [9] .
This study was designed to determine whether intake of highdose α-lipoic acid before running eccentric exercise demonstrates antioxidative activity and enhances EPO release through changes in RN/OS generation.
MATERIALS AND METHODS
Sixteen healthy males participated in this randomised and placebocontrolled study (Table 1) . During the study, subjects were requested to avoid nutritional supplements and physical effort for 48 h before and after the exercise trials. All the subjects were informed of the aim of the study and gave their written consent for participation in the project. The protocol of the study was approved by the local ethics committee in accordance with the Helsinki Declaration.
The maximal oxygen uptake (VO 2 max) was determined on a treadmill Trackmaster TM310 (USA) at the temperature of 22°C and the relative air humidity of 60%. Breath-by-breath oxygen uptake was continuously recorded using the Oxycon Mobile ergospirometric system (Viasys Healthcare Inc., USA). Heart rate was continuously recorded during the test using a portable heart rate telemetry device:
Polar Sport Tester T61 (Finland). The test was incremental and progressive; all subjects commenced at a 4.5 mph running speed and it was increased by 0.5 mph every 2 min until the maximal level of recorded parameters was achieved. The VO 2 max was determined between 8 a.m. and 2 p.m. a week before the beginning of the experiment.
The subjects were assigned to one of two groups: placebo and α-lipoic acid (Thiogamma 600 Wörwag Pharma; 2 x 600 mg · d -1 for 10 days prior to the exercise trial). The exercise trial involved a 90-min run at 65% VO 2 max (0% gradient) followed by a 15-min ec- .
The intra-assay coefficients of variation (CV) for LPO and PC kits were <10%.
Erythropoietin
Serum erythropoietin (EPO) level was determined by the enzyme immunoassay method using a commercial kit from R&D Systems (USA).
The EPO detection limit for the applied kit was 0.6 mIU · mL -1 .
The intra-assay CV for the EPO kit was <8%.
Haematological variables
Haemoglobin (HB), haematocrit (HCT), mean corpuscular volume (MCV), mean corpuscular haemoglobin (MCH) and mean corpuscular haemoglobin concentration (MCHC) as well as erythrocyte (RBC) and reticulocyte counts (RET) and reticulocyte relative number (percentage) (RET%) were assessed using Sysmex XE-2100 (Japan)
in EDTA blood samples.
Creatine kinase
Total serum creatine kinase (CK) activity was used as a marker of muscle damage and was evaluated using an Emapol kit (Poland).
The CK detection limit for the applied kit was 6 IU · L -1
. The intraassay CV for the CK kit was 1.85%.
Statistical analysis
A two-way analysis of variance (ANOVA) with repeated measures was used to determine the effect of exercise and α-lipoic acid on analysed parameters [(pre-exercise vs. post-exercise) x (placebo vs. ences between group means. The relationships between variables were determined using Pearson's correlation and linear regression.
All results are expressed as mean and standard deviation (x ± SD). 
RESULTS

Reactive nitrogen/oxygen species
The running eccentric exercise caused a significant increase in NO α-Lipoic acid reduced the NO/H 2 O 2 ratio 2-fold at pre-exercise, 20 min and 24 h, but elevated it at 48 h after exercise ( Table 2) .
Markers of RN/OS activity
The running eccentric exercise significantly elevated 8-iso, LPO and PC concentrations at 20 min and 24 h after exercise. α-Lipoic acid prevented post-exercise changes in 8-iso, LPO and PC levels; thus it revealed antioxidative activity. However, there were no significant differences in LPO and PC between placebo and α-lipoic acid (Table 2) .
Erythropoietin
The exercise trial significantly increased EPO concentration at 20 min Figure 1) . EPO also correlated with total CK activity (r = 0.478, P<0.01), which reached a peak at 24 h after exercise (Figure 2 ). This means that changes in RN/OS generation and muscle damage are important factors affecting EPO release.
Haematological variables
HB concentration did not change following exercise but it was significantly elevated after α-lipoic acid at pre-exercise, 20 min, and 24 h post-exercise. Other haematological variables did not change after either exercise and α-lipoic acid; however, RBC and RET numbers as well as MCV tended to high values after α-lipoic acid intake (Table 3) .
Creatine kinase
Total initial CK activity was slightly lower in the α-lipoic acid group than in placebo but the difference was not statistically significant.
Interestingly, in the group treated with α-lipoic acid, CK activity was
FIG. 2. THE RELATION OF ERYTHROPOIETIN (EPO) LEVEL TO TOTAL CREATINE KINASE (CK) ACTIVITY FOLLOWING EXERCISE TRIAL IN α-LIPOIC ACID GROUP (N = 8)
Note: r = 0.478, P<0.01.
FIG. 3. CHANGES IN TOTAL SERUM CREATINE KINASE (CK)
Note: *P<0.05, **P<0.01 and ***P<0.001 significantly different compared with pre-exercise level. CK activity was significantly different (P<0.05) in α-lipoic acid compared with placebo at 24 h post-exercise. 
DISCUSSION
Many studies have concluded that intracellular RN/OS production is a required signal for the exercise adaptation that occurs in the cardiovascular system and skeletal muscles in response to repeated exercise [29] . The applied high α-lipoic acid dose increased H 2 O 2 but reduced NO concentration. This could be caused by inhibition of an inducible isoform of NOS expression by α-lipoic acid through destabilization of its mRNA, resulting in decreased NO production [35] . The excess NO reacts with the superoxide anion to produce peroxynitrite (ONOO -), which can induce mitochondrial dysfunction, lipid and protein oxidation [28] . α-Lipoic acid shows the ability to react directly with ONOO -and to reduce nitro-oxidative stress [33] . It has been demonstrated to be effective in preventing various diseases in which RN/OS have been implicated, such as cardiovascular diseases, diabetes, hypertension and radiation injury [30] .
The measure of RN/OS markers such as 8-iso, LPO and PC can offer an empirical view on the complex process of peroxidation and carbonylation followed by diseases, aging or exhaustive exercise [29] .
Our study confirmed the effectiveness of α-lipoic acid in the protec- was previously indicated as part of the O 2 -sensing mechanism stabilizing transcription factor HIF-1 and regulating EPO expression, and as a signal for cell growth and differentiation of erythroid progenitor cells [17] . The next observations indicated the key role of NO in HIF-1α stabilization [6] . According to Haase [13] , during hypoxia transcriptional activity of HIF-1 is more dependent on changes in H 2 O 2 , whereas during non-hypoxic conditions HIF-1 activity is related to NO, pro-inflammatory cytokines IL-β and TNFα, as well as growth factors including epidermal growth factor, insulin, and insulin-like growth factor I. We observed that α-lipoic acid elevates α-Lipoic acid can effect muscle regeneration through regulation of RN/OS and EPO production. Endogenously produced EPO and/or expression of the EPO receptor gives rise to autocrine and paracrine signalling in skeletal muscles particularly during hypoxia and injury conditions. In the last decade, numerous studies have confirmed that apart from its haematopoietic effect, EPO is active in muscle, neural, endothelial, cardiovascular and renal tissues [21, 25] . In skeletal muscles, EPO stimulates proliferation of myoblasts and has a potential role in muscle mass maintenance. Furthermore, EPO directly contributes to increased PGC-1α activity and affects skeletal muscle development and the balance of slow and fast-twitch fibre determination [34] . High α-lipoic acid intake increased EPO concentration and reduced total CK activity at 24 h and 48 h after exercise.
A significant positive correlation was observed between CK and EPO.
Mille-Hamard et al. [25] reported that EPO exerts both direct and indirect muscle-protecting effects during intense exercise. However, the authors stressed that the signalling pathway involved in protective effects of EPO remains to be described in detail.
The increase in serum CK activity is normally related to intense physical activity and strongly correlates with the type and the amount of exercise. It depends on the degree of injury of the skeletal muscle cell structure. Therefore, CK is widely used in monitoring of training load, physical efficacy and overtraining in athletes. The skeletal muscles performing eccentric exercise are particularly exposed to damage as the result of disruption of sarcomeres, leading to intensified CK efflux into the extracellular space and markedly higher CK activity in the blood [24] . The study revealed differences in CK response to eccentric exercise depending on α-lipoic acid intake. Participants supplemented with α-lipoic acid had significantly lower CK activity than control individuals taking placebo. This was in line with earlier observations of Kim and Chae [20] , who demonstrated significantly lower CK values in rats supplemented with α-lipoic acid for 6 weeks irrespectively of exercise. One of the postulated reasons of lower muscle injury could be membrane protective effects of α-lipoic acid against exercise-induced oxidative damage as the result of attenuation of lipid peroxidation and membrane permeability [12] .
Although the CK activity shows remarkable intra-and inter-individual variations under exercise condition, some authors have defined a blurred boundary between harmless and damaging physical activities at the level of about 300-500 IU · mL -1 of the enzyme activity [3] . α-Lipoic acid intake significantly reduced excessive CK efflux REFERENCES during exercise performance thus suggesting its muscle protective capabilities in the study. This highly beneficial effect could be a matter of particular interest for the future in preventing an extremely high CK response to exercise rhabdomyolysis in athletes [4, 19] and statin-induced rhabdomyolysis in a substantial proportion of patients treated for dyslipidaemia [5, 32] .
CONCLUSIONS
In conclusion, the current results confirm the antioxidative properties of α-lipoic acid, and indicate a possible use of α-lipoic acid to improve EPO production and skeletal muscle regeneration through changes in the RN/OS ratio at rest and after exercise.
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